Unless the "controlled launch" was actually a real world test to demonstrate with high prescribing/highly respected Endo's how effective afrezza really is.
If they know its as good as advertised they would be foolish to wait until sales take off to buy.
Yes I saw this on stock twits this morning too. I thought it was very interesting how they called it an example of a non-traditional launch strategy.
Novartis Joins With Google to Develop Contact Lens That Monitors Blood Sugar
They have already partnered with Novartis on this patented technology. Wonder what the nature of the Google SNY agreement surrounds?
Frustrated but still here. SNY has proven to be a terrible partner. How after over a year on the market can the majority of diabetics STILL have no idea Afrezza exists. Mind boggling. I have no idea what they are doing, if anything. It would have AT LEAST been nice to hear that they were committed to Afrezza at their last CC. Couldn't even do that.
Outstanding move on our part wasn't it?? We could have had that all behind us.
God I hope so Kevin. Soft launch plus information vacuum is disheartening
Exactly Kenneth. Marketing by afrezza is non-existent! How can two print adds in time magazine be considered any kind of real marketing? Their efforts to date are pathetic. The only marketing done to date has been done by Sam.
If we can just get to 1800 scripts per week, and get rid of SNY, we have enough sales to justify 7.00 pps. SNY isn't stupid they know this too.
With ANY marketing at all we would already be at 1800 per week. Considering Sam has provided our only marketing free of charge our numbers are with-in striking distance of 1800.
My honeymoon with SNY is over.
At this moment, my theory is looking more like wishful thinking. Lets see how this plays out today. Good luck!
I've been if this opinion for some time that shorts are margined and using broader market gains to fund their positions. IMHO last Friday's action supports this position. It appears that this belief will be further tested today.
If we get a good enough correction shorts not margined just may take gains to buy back into the broader market.
If we can just get some script movement in the right direction we could get some momentum in the right direction. Good luck all longs.
DEFINITION of 'Marketing'
The activities of a company associated with buying and selling a product or service. It includes advertising, selling and delivering products to people. People who work in marketing departments of companies try to get the attention of target audiences by using slogans, packaging design, celebrity endorsements and general media exposure. The four 'Ps' of marketing are product, place, price and promotion.
As far as I can tell SNY isn't doing squat, when the vast majority of diabetics STILL have never hear of afrezza let alone have any idea about its benefits.
I don't know what the grand plan is but up to this point marketing afrezza isn't one of them.
I've not sold a share. Only added.
He always twists the "facts". Immediately following the announcement of the debt restructuring he called it death spiral financing. Now he's is saying it was "like" death spiral financing. He has a grudge against MNKD for whatever reason.
I agree. I have never liked the attacks on Afrezza users. Its bad form for all of us.
Adverse/ sub-optimal results are to be expected and can be a very fruitful place to sharpen our understanding of Afrezza. We will not gain that insight if we attack at the least provocation.
In defense of MNKD investors, the constant short and distort has made many trigger happy.
I get it Red, but I have to respect George (I've no doubt he knows more than me) and believe that there were other ways to resolve this issue that were better than what they came up with.
I stand by my statement "unless they are aware of a material event that will propel the stock price well above the basement price of 4.60". If that is the case then I stand behind their decision.
I am simply stating what George said in his comments yesterday. Do you like the way they handled the debt? Please elaborate?
I personally hate the fact that they drug this out for yet another month, unless they know there is a short term catalyst.
Right? Otherwise as George Rho stated this is the dumbest way possible to deal with the debt. The only 'smart" reason to extend is if there know there is a material event in the near term which will make the conversion greater than the 4.60 basement price. I'm not sure I am holding out much hope unfortunately.
I have to agree with the majority of what you are saying. I an especially annoyed with SNY. They have done NOTHING as far as I can tell to support our drug. What percentage of diabetics and doctors STILL have never heard of Afrezza?